Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alkermes (ALKS) Cost of Revenue (2016 - 2025)

Alkermes (ALKS) has disclosed Cost of Revenue for 16 consecutive years, with $46.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 25.61% to $46.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $196.5 million, a 52.02% decrease, with the full-year FY2025 number at $196.5 million, down 19.92% from a year prior.
  • Cost of Revenue was $46.2 million for Q4 2025 at Alkermes, up from -$93.9 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $307.2 million in Q4 2023 to a low of -$93.9 million in Q3 2025.
  • A 5-year average of $84.3 million and a median of $59.9 million in 2022 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: soared 325.36% in 2022, then plummeted 191.98% in 2025.
  • Alkermes' Cost of Revenue stood at $53.6 million in 2021, then skyrocketed by 325.36% to $228.1 million in 2022, then soared by 34.72% to $307.2 million in 2023, then plummeted by 79.78% to $62.1 million in 2024, then decreased by 25.61% to $46.2 million in 2025.
  • Per Business Quant, the three most recent readings for ALKS's Cost of Revenue are $46.2 million (Q4 2025), -$93.9 million (Q3 2025), and $121.2 million (Q2 2025).